Obesity drugs alter eating behaviors More than half of participants said they had either a slight or large reduction in appetite with obesity therapy, including 54.4% of the Wegovy group, 62.1% of the Ozempic group and 56.5% of the Mounjaro group
Maintain open communication with our office about any questions or unusual symptoms you experience
While most people would say this is normal during a pregnancy, many have stated the intensity of their symptoms is unlike that of their previous pregnancies. Why are pregnant women experiencing extreme hunger and rapid weight gain after taking Ozempic
Now, we are excited to offer yet another new medically supervised weight loss program: **the Semaglutide Weight Loss Program
For evidence-based obesity and pharmacotherapy context, the Endocrine Society obesity pharmacotherapy guideline provides clinical background on medication use within broader care
The Promise of GLP-1 Receptor Agonists for Neurodegenerative Diseases